In a significant breakthrough for the diabetes community, Lilly’s groundbreaking diabetes drug, Mounjaro, has received the coveted stamp of approval…
Eli Lilly’s Q2 Profits Surge 85%: Mounjaro and More Drive Growth
The pharmaceutical industry is witnessing an impressive triumph as Eli Lilly, a prominent player in the field, reports a staggering…
Woman Sues Ozempic and Mounjaro: Gastrointestinal Issues
In a recent development, a woman has filed a lawsuit against the manufacturers of Ozempic and Mounjaro, claiming that these…